Biopharma Daily Stock Updates - 01/12/21

Updated: Jan 13

$XBI $149.35 (+0.87%) 📈


$MRNA (+6.22%) - Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland


$MESO (-10.18%) - CHF Phase 3 Trial Results Presented at Investor Conference

$MIRM (+5.04%) - News Release Details Mirum Pharmaceuticals Provides Corporate Update

$TVTX (+1.07%) - Travere Therapeutics Announces Orphan Drug Designation for Sparsentan for the Treatment of IgA Nephropathy

$MRUS (+20.30%) - Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium

$OTLK (-1.59%) - Leading Ophthalmology Organization Launches Podcast Video with Firas Rahhal, MD, to Explore the Genesis and Promise of Outlook Therapeutics’ ONS-5010/LYTENAVA™ (bevacizumab-vikg)


$MNOV (+0.54%) - MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners

$CERC (+8.87%) - Closed offering priced at $2.60/share

$RGNX (+1.27%) - Closed offering priced at $47/share

$RDHL (-13.66%) - RedHill Biopharma Increases Previously Announced Bought Deal to $25 Million


*Disclaimer: Information provided on and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Big Movers™ is a trademark of Amp Biotech Research, LLC

©2021 by Biopharm IQ. Website by Awaken Studio.